Recommended assessment | Rationale | Frequency | Recommended for all ASMD or as needed |
---|---|---|---|
Baseline history | Establish natural history, systemic involvement, current level of disease severity and estimate rate of progression | At diagnosis | All |
Interval history | Establish rate of disease progression; monitor for compliance with and side effects from therapy | 3–12 monthly/each visit | As needed |
Physical examination | Document growth parameters, assess for neurological features and organomegaly, assess for fatigue, abdominal pain, and/or bleeding tendency at least annually | At diagnosis then 6–12 monthly/each visit | As needed |
Nutrition | Evaluation of nutritional status and safety of oral intake | At diagnosis then at each visit | As needed |
Pulmonary assessment | Assess recurrent chest infections | At diagnosis then at each visit | All |
Assess for shortness of breath | |||
Pulmonary function testing including assessment of diffusing capacity in persons old enough to cooperate | At diagnosis then annually | As needed | |
Chest radiograph and/ or high resolution chest CT to assess extent of interstitial lung disease | At diagnosis regardless of age then every 2–4 years | All | |
Musculoskeletal assessment | Assess for fractures and/or extremity pain | At diagnosis then each visit | All |
Neurologic assessment | Comprehensive neurologic evaluation, assess neurologic function and frequency of headaches | At diagnosis then annually | As needed |
Ophthalmology evaluation | Presence of cherry-red spots at baseline and document | At diagnosis | All |
Cardiac assessment (adult only) | EKG, echocardiogram, coronary angiogram as indicated | At diagnosis | As needed |
Every 3–5 years | |||
Blood investigations | Serum chemistries including liver transaminases (ALT, AST), albumin, and clotting factors to evaluate for progression of hepatic dysfunction | At diagnosis then at least annually | As needed |
Complete blood count to evaluate for thrombocytopenia, leukopenia, anemia, and increased bleeding | |||
Measurement of lipid profile | |||
Imaging studies | Radiologic measurements of liver and spleen size as needed | At diagnosis then as needed | As needed |
Liver elastography or FibroScan to evaluate for hepatic fibrosis and cirrhosis | |||
Swallowing assessment | Swallowing assessment in all patients at risk; document presence of dysphagia and aspiration and response to therapy | At diagnosis and then 6 monthly in children; in adults, frequency could be reduced to every | As needed |
12 months if asymptomatic and disease is stable | |||
Developmental or cognitive assessment | Developmental assessment, monitor developmental progress and educational needs (evaluation for early intervention/special education) | At diagnosis then at each visit | As needed |
Document baseline degree of cognitive impairment including motor, adaptive, cognitive and speech/language and monitor response to therapy | At diagnosis; 6 monthly in children; 12 monthly in adults | As needed | |
Neuropsychiatric evaluation | Document psychiatric manifestations and response to therapy | At diagnosis then 6–12 monthly as indicated | As needed |
Family support and resources | Assess need for family support and resources at each visit | At diagnosis then each visit | As needed |
Assess need for community or online resources such as Parent to parent; social work involvement for parental support | |||
Home nursing referral | |||
Assess for any change in social, domestic, or school or work related activities |